|Podcasts|May 25, 2022
Pharmacy Focus: Independent Rx Forum- DIR Fees and Recent Rulemaking From CMS
Independent pharmacies' constant battle over the years to try and get relief for NCPA members on these retroactive DIR fees have been really the number one issue.
Advertisement
Today's episode features Ronna Hauser and Karry La Violette from NCPA who discuss the most recent rules from CMS and how it will impact DIR fees in the pharmacy landscape.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
What Pharmacists Should Know About Most Favored Nation as Drug Prices Continue to Rise
2
From Underdiagnosed to Under Control: Plozasiran and Pharmacists’ Role in FCS
3
Positive Phase 2a Trial Supports FDA Clearance of StemCyte’s HPC Therapy for Long COVID Patients
4
FDA Grants Orphan Drug Designation to Zavabresib for the Treatment of Myelofibrosis
5